Heart failure in children with cardiomyopathy. Which markers can be used to predict outcome?

Heart failure in children with cardiomyopathy. Which markers can be used to predict outcome? - Cardiomyopathy in children

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39252

Enrollment

120

Registered

2010-08-26

Start date

2010-10-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiomyopathy heart muscle disease

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Children with dilated cardiomyopathy

Exclusion criteria

Exclusion criteria: inabilty to cooperate with the study protocol (i.e mental retardation) For specific procedures within the protocol general accepted contra-indications may apply. Specifiically, for MRI the presence of MRI incompatible materials in the body and for the application of contrast because of renal impairment.

Design outcomes

Primary

Measure	Time frame
o death, heart transplantation or institution of mechanical support of the circulation	—

Secondary

Measure	Time frame
o listing for heart transplantation, hospitalization for worsening heart failure, hospitalization for all causes	—

Countries

Netherlands

Outcome results